Egalet (STU:EGP) Total Liabilities: €185.33 Mil (As of Mar. 2020)


What is Egalet Total Liabilities?

Egalet STU:EGP Total Liabilities is €185.33 Mil as of Mar. 2020. The stock has 2 warning signs investors should review.

Egalet's Total Liabilities for the quarter that ended in Mar. 2020 was €185.33 Mil.

Egalet's quarterly Total Liabilities declined from Sep. 2019 (€173.11 Mil) to Dec. 2019 (€169.20 Mil) but then increased from Dec. 2019 (€169.20 Mil) to Mar. 2020 (€185.33 Mil).

Egalet's annual Total Liabilities increased from Dec. 2017 (€134.55 Mil) to Dec. 2018 (€152.33 Mil) and increased from Dec. 2018 (€152.33 Mil) to Dec. 2019 (€169.20 Mil).

Egalet Total Liabilities Historical Data

* Premium members only.

The historical data trend for Egalet's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet Total Liabilities Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 76.37 103.84 134.55 152.33 169.20

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 166.66 157.44 173.11 169.20 185.33

Egalet Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Egalet's Total Liabilities for the fiscal year that ended in Dec. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=68.194+(86.184+14.818
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=169.20

Total Liabilities=Total Assets (A: Dec. 2019 )-Total Equity (A: Dec. 2019 )
=207.348-38.152
=169.20

Egalet's Total Liabilities for the quarter that ended in Mar. 2020 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=84.202+(86.413+14.714
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=185.33

Total Liabilities=Total Assets (Q: Mar. 2020 )-Total Equity (Q: Mar. 2020 )
=207.678-22.35
=185.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €185.33 Mil mean?
Egalet (STU:EGP) has a Total Liabilities of €185.33 Mil as of Mar. 2020. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Egalet and its competitors.
Is Egalet's Total Liabilities too high?
Egalet's current Total Liabilities is €185.33 Mil.
How does Egalet's Total Liabilities compare to CPHI and TLGT?
Egalet's Total Liabilities of €185.33 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Egalet and its competitors. Egalet's current Total Liabilities is €185.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current Total Liabilities of €185.33 Mil. The current Total Liabilities is €185.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Egalet (STU:EGP), the current Total Liabilities is €185.33 Mil as of Mar. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.